The Company said it has made substantial progress on its strategic infrastructure and operating initiatives. "We are well on our way with construction and recruiting efforts at our recently announced Shannon, Ireland facility, and we are making additional investments across our global manufacturing network," Mr. Dvorak said. "Further, the April 17, 2008, announcement of our enhanced compliance model was an important milestone for our Company. These are all critical steps in preparing our Company to better serve the healthcare markets of the future."
The Company also announced that its Board of Directors has approved an additional $1.25 billion stock repurchase program, which expires on December 31, 2009. This is in addition to the remaining capacity of $477 million as of March 31, 2008, under the repurchase program authorized in December 2006. Purchases may be made in the open market or in privately negotiated transactions from time to time in compliance with Securities and Exchange Commission regulations, depending on market conditions and other factors. The Company had approximately 231.5 million shares of common stock outstanding as of March 31, 2008.
"As we continue to evaluate our potential uses of cash and other resources, the Board has confirmed that repurchasing shares is consistent with our confidence in the Company's long-term growth prospects and provides an effective avenue to return value to our stockholders," said Mr. Dvorak.
Sales Tables
The following tables provide sales results by geographic segment and
product category, as well as the percentage change compared to the prior
year quarter on both a reported and constant currency basis.
NET SALES - THREE MONTHS ENDED MARCH 31, 2008
(in millions, unaudited)
Constant
Net Reported
'/>"/>
| SOURCE Zimmer Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved |